Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – The Hill” style=”width:100%;max-height:420px;object-fit:cover;border-radius:8px;display:block;” />#78 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians need to recognize cannabinoid hyperemesis syndrome (CHS) as an increasingly common diagnosis in regular cannabis users presenting with severe nausea and vomiting, as delayed recognition can lead to unnecessary diagnostic testing and prolonged patient suffering. Identifying CHS requires a detailed cannabis use history and understanding its characteristic cyclic symptom pattern, allowing providers to offer definitive treatment through cannabis cessation rather than pursuing invasive investigations. Patients who use cannabis regularly, particularly high-potency products, should be counseled about this risk and educated that cessation is the only proven treatment, even though symptoms may temporarily worsen before resolution.
Cannabinoid hyperemesis syndrome (CHS), a paradoxical condition characterized by severe nausea and vomiting in chronic cannabis users despite symptom relief from acute use, is increasing in prevalence as cannabis potency and consumption rates rise. The syndrome typically manifests in three phases: prodromal symptoms of mild nausea and decreased appetite, hyperemetic episodes of severe vomiting often accompanied by compulsive bathing behaviors, and a recovery phase following cannabis cessation. CHS presents a diagnostic challenge because affected patients often continue using cannabis believing it will alleviate symptoms, when cessation is actually the only effective treatment. Clinicians should recognize this emerging condition in patients reporting recurrent nausea and vomiting resistant to standard antiemetics, particularly those with heavy cannabis use histories, as misdiagnosis can delay appropriate management and lead to unnecessary investigations and hospitalizations. The increasing potency of modern cannabis products, especially concentrates and edibles, may be contributing to the rising incidence of CHS among both adolescent and adult populations. Physicians should counsel chronic cannabis users about this potential adverse effect and consider CHS in the differential diagnosis of intractable nausea, educating patients that cannabis abstinence remains the definitive treatment.
“Cannabinoid hyperemesis syndrome is a real clinical entity that we’re seeing with increasing frequency, particularly in patients using high-potency products daily, and the key to managing it is recognizing that standard antiemetics often fail until cannabis use stops completely. I counsel patients that this syndrome represents a genuine pathophysiologic response to chronic cannabinoid exposure, not a psychological condition, and the only reliable treatment is cessation, which typically resolves symptoms within days to weeks.”
💊 Cannabinoid hyperemesis syndrome (CHS) represents an emerging clinical entity that clinicians should recognize, particularly as cannabis potency and consumption patterns evolve. The syndrome presents paradoxically with severe nausea and vomiting in chronic cannabis users despite their continued use, and is often accompanied by compulsive hot bathing that provides temporary symptom relief—a feature that can help distinguish it from other causes of intractable vomiting. While the pathophysiology remains incompletely understood and individual susceptibility factors are not yet clearly defined, increasing case reports suggest rising prevalence correlates with higher-potency products and increased frequency of use. Clinicians should maintain a high index of suspicion for CHS in patients presenting with unexplained cyclic or refractory nausea and vomiting, particularly those with regular cannabis use, and recognize that standard antiemetic agents often prove ineffective. The most practical clinical approach
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
